Biofrontera (BFRI)

• Market cap: $10.8M
• 1 day: 1.23%
• 5 days: 8.87%
• 1 month: -7.13%
• 3 months: 17.54%
• 6 months: 2.98%
• Year to date: 27.83%
• 1 year: -9.14%
• 5 years: -98.95%
• 10 years: -98.95%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93